• DongKoo Bio & Pharma’s controlling shareholder Cho Yong Joon kept his stake unchanged at 10,604,678 shares, or 37.18%, as of Oct. 7.
• Shares under pledge contracts edged down to 7,565,698 shares, or 26.52%, from 7,567,885 shares, or 26.53%.
• The filing cited partial repayment of collateralized loans as the reason for the change, with the obligation triggered on Sept. 30.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKoo Bio & Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000585), on October 08, 2026, and is solely responsible for the information contained therein.